Experience
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Apotex Corp. et al
Counsel for Otsuka in Hatch-Waxman cases involving 24 companies seeking to market generic copies of Abilify® following expiration of compound patent covering active ingredient in Abilify®. Only one case still pending following confidential resolutions of all other matters.
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp. et al, 1:14-cv-01078, -04671, -02982, -07405, -05878, -06398 -08074 -03306, -06890, -05876, -08077, -03168, -07252, -07105 -05537, -03996, -06158, -04508, -04307, -06397, -07106, -01979, -03445; 1:15-cv-0161, -07584, -01585, -07803, -08830, -05109, -07802, -08955, -01716, -01967, -06353, -08305; 1:16-cv-05288, -05400, -05949, -07705 -02475, -02476, -08284, -05743, -00086, -08085, -00555, -00557, -07346, -06067, -00405, -00424, -05688, -09603; 1:17-cv-02754, -00392, D.N.J., Judges Simandle, Williams
